- TickerWFC
- ISINUS9497461015
- ExchangeNew York Stock Exchange
- SectorBanks
- CountryUnited States
Profitability, capital and liquidity metrics build on the improvements of Q3. However, Q4 was credit neutral as net income remains weak and efficiency remains poor.
Waiting on Small-Caps This market continues to be dominated by signals that suggest we are in the early stages of a new bull phase, which we discuss below. At the same time, small-caps continue to be one area of the market that gives us some reason for pause as neither the Russell 2000 or S&P Small Cap 600 indexes have been able to make bullish price or RS inflections. • Small-Caps Still Below Resistance. The major US large- and mid-cap indexes have all decisively broken out to either all-time highs or 52-week highs, leaving small-caps behind. This situation can only happen for so long bec...
Dramatic improvement Encouraging developments continue to pour in. Over the past week we have seen dramatic improvements that could be setting the stage for a broad-based advance. We highlight these improvements below, along with what we would like to see in order to have confidence in labeling this a bull market. • 10-year Treasury yield. We continue to believe that a bottom in Treasury yields is necessary before we see a decisive breakout for the broad equity market. We are seeing signs of this bottom happening -- not only in the absolute chart of the 10-year Treasury yield, but also in ...
Key Points: • A number of Financial Sector names are at or near bullish price and RS inflections. (ex. WFC, ABCB, SNV, STL, NFBK, FII, and COF) • Many Healthcare Sector names are showing leadership characteristics. (ZBH, CUTR, UHS, HCA, CHE, AMED, WST, and NEOG) • Many IT service related names remain bullish. (ex. FISV, EBOV, GPN, TSS, and EXLS)
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Summary KeyCorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights KeyCorp (KeyCorp or 'the group') is a financial services company. The group offers retail and commercial banking, commercial leasing, investment management, consumer finance, commercial mortgage servicing and special servicing, and investment banking products and services to individual, corporate, a...
Summary Marketline's First Foundation Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by First Foundation Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advant...
Profitability, capital and liquidity metrics build on the improvements of Q3. However, Q4 was credit neutral as net income remains weak and efficiency remains poor.
The independent financial analyst theScreener just awarded an improved star rating to WELLS FARGO & CO (US), active in the Money Center Banks industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 4 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date October 9, 2020, the closing price was USD 25.30 and its expected value was estimated at USD 24.42.